Pharmaceuticals
This Pharma Presents a Potential 'Lose-Win' Situation for Patients and Investors
Two in five Americans are obese. Treatments that target obesity directly could be the next blockbuster pharma category.
Walgreens Could Continue to Weaken
The company reported earnings and the shares have rolled over and turned down.
NovoCure Gaps Sharply Higher for a Breakout: How to Play It
Let's check out the charts and indicators of both NovoCure and Zai Lab.
Teva Pharmaceutical Rallies, So Let's Adjust Our Bullish Strategy
The shares rallied nicely in December.
Acadia Pharmaceuticals Bulls Will Need to Be Patient for Now
The company's charts simply aren't showing sustained strength.
Expect Biotech to Head Higher in 2023
Let's dip into the biotech mailbag as the year comes to an end.
Pfizer May Not Be a Growth Play But It's a Good Stock for Tough Times
PFE is fundamentally sound and certainly not overvalued.
Merck's Stock Could Keep Climbing Higher
Here's what traders should do now.
I'm Going to Give This Biotech Another Shot
Here's a booster for my May Dynavax Technologies trade.
I'm Looking for a Basing Pattern With This Popular Biotech ETF
The charts of this ETF have upside promise, thanks in part to a number of its larger holdings displaying positive-looking charts.